Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For young people with Sickle Cell Disease (SCD):
- People between Tanner stages 1–5 (roughly ages 10–17) with a diagnosis of sickle cell disease in any relevant form
- People considered to be in relatively good health for someone with SCD, with no SCD complications that a doctor considers would make participation unsafe
- People with no other illness or disability that would prevent participation in physical activity
- People whose doctor has given permission to take part in a cardiopulmonary exercise test (a supervised breathing and fitness test)
- People whose body weight falls within the typical range for their age and condition
For young people with Cystic Fibrosis (CF):
- People between Tanner stages 1–5 (roughly ages 10–17) with a confirmed CF diagnosis, either through two CF-related gene mutations and/or a sweat chloride test result above 60 mmol/l
- People considered to be in relatively good health for someone with CF, with no CF complications — such as severe lung bleeding or significant lung blood pressure problems — that a doctor considers would make participation unsafe
- People whose body weight falls within the typical range for their age and condition
- People with no other illness or disability that would prevent participation in physical activity
For healthy comparison participants:
- People between Tanner stages 1–5 (roughly ages 10–17) who are considered to be in good health following a health check by a primary care provider or trial staff
- People whose body weight and physical activity levels fall within the typical range for their age
- People with no illness or disability that would prevent participation in physical activity
For participants who have had a COVID-19 (SARS-CoV-2) infection:
- People between Tanner stages 1–5 (roughly ages 10–17) with a documented COVID-19 infection
- People whose primary care provider or trial medical staff consider to be capable of doing exercise
Who may not be able to join:
For young people with Sickle Cell Disease:
- People currently receiving regular monthly blood transfusions
- People with other conditions that prevent exercise, such as a neurological movement disorder, heart disease, or any similar condition
- People currently being treated for substance or alcohol misuse
For young people with Cystic Fibrosis:
- People whose lung function (FEV1) is below 40% of the expected level for their age and size
- People with a current infection with specific bacteria — Burkholderia cenocepacia or Mycobacterium abscessus (confirm with trial site)
- People with other conditions that prevent exercise, such as a neurological movement disorder, heart disease, or any similar condition
- People currently being treated for substance or alcohol misuse
For healthy comparison participants:
- People currently being treated for substance or alcohol misuse, or who are taking ongoing regular medications
- People considered unsuitable for exercise by trial staff
For COVID-19 comparison participants:
- People currently being treated for substance or alcohol misuse, or who are taking ongoing regular medications
- People considered unsuitable for exercise by trial staff
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (714) 456-8248
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gas Exchange Variables; Whole Body Lean Mass; Physical Activity; Biomarkers; Gene Expression; Gas Exchange Variables; Gas Exchange Variables; Gas Exchange Variables; Gas Exchange Variables; Gas Exchange Variables; Gas Exchange Variables; Fat Mass; % Body Fat; Whole Body Bone Mineral Content; Whole Body Bone Mineral Density; Biomarkers; Biomarkers; Biomarkers; Biomarkers; Biomarkers; Biomarkers; Biomarkers; Gene Expression; Gene Expression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.